25 XP   0   0   10

BioGaia AB (publ)
Buy, Hold or Sell?

Let's analyse Biogaia together

PenkeI guess you are interested in BioGaia AB (publ). Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of BioGaia AB (publ). At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about BioGaia AB (publ)

I send you an email if I find something interesting about BioGaia AB (publ).

Quick analysis of Biogaia (30 sec.)










What can you expect buying and holding a share of Biogaia? (30 sec.)

How much money do you get?

How much money do you get?
kr0.53
When do you have the money?
1 year
How often do you get paid?
72.5%

What is your share worth?

Current worth
kr20.11
Expected worth in 1 year
kr20.68
How sure are you?
95.0%

+ What do you gain per year?

Total Gains per Share
kr6.41
Return On Investment
5.4%

For what price can you sell your share?

Current Price per Share
kr118.50
Expected price per share
kr109.40 - kr135.60
How sure are you?
50%

1. Valuation of Biogaia (5 min.)




Live pricePrice per Share (EOD)

kr118.50

Intrinsic Value Per Share

kr31.99 - kr54.49

Total Value Per Share

kr52.10 - kr74.60

2. Growth of Biogaia (5 min.)




Is Biogaia growing?

Current yearPrevious yearGrowGrow %
How rich?$185.1m$171.5m$10.5m5.8%

How much money is Biogaia making?

Current yearPrevious yearGrowGrow %
Making money$8.3m$8.5m-$191.9k-2.3%
Net Profit Margin28.0%34.0%--

How much money comes from the company's main activities?

3. Financial Health of Biogaia (5 min.)




What can you expect buying and holding a share of Biogaia? (5 min.)

Welcome investor! Biogaia's management wants to use your money to grow the business. In return you get a share of Biogaia.

What can you expect buying and holding a share of Biogaia?

First you should know what it really means to hold a share of Biogaia. And how you can make/lose money.

Speculation

The Price per Share of Biogaia is kr118.50. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Biogaia.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Biogaia, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is kr20.11. Based on the TTM, the Book Value Change Per Share is kr0.14 per quarter. Based on the YOY, the Book Value Change Per Share is kr0.06 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is kr1.46 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Biogaia.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 kr% of Price per Sharekr% of Price per Sharekr% of Price per Sharekr% of Price per Sharekr% of Price per Share
Usd Eps0.060.1%0.080.1%0.080.1%0.060.1%0.050.0%
Usd Book Value Change Per Share0.040.0%0.010.0%0.010.0%0.070.1%0.040.0%
Usd Dividend Per Share0.000.0%0.130.1%0.270.2%0.130.1%0.100.1%
Usd Total Gains Per Share0.040.0%0.150.1%0.280.2%0.200.2%0.140.1%
Usd Price Per Share9.23-9.34-18.79-31.35-28.23-
Price to Earnings Ratio37.93-29.82-64.51-185.35-185.01-
Price-to-Total Gains Ratio226.77-115.40-84.10-344.73-362.13-
Price to Book Ratio5.03-5.20-10.84-40.53-53.23-
Price-to-Total Gains Ratio226.77-115.40-84.10-344.73-362.13-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share10.8072
Number of shares92
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.130.13
Usd Book Value Change Per Share0.010.07
Usd Total Gains Per Share0.150.20
Gains per Quarter (92 shares)13.4418.29
Gains per Year (92 shares)53.7673.15
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
149544482563
29810989650136
31471415214575209
419619206193100282
524524260241125355
629429314289150428
734334368337175501
839238422385200574
944043476434225647
1048948530482250720

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%40.00.00.0100.0%60.00.00.0100.0%
Book Value Change Per Share3.01.00.075.0%9.03.00.075.0%16.04.00.080.0%30.010.00.075.0%43.015.02.071.7%
Dividend per Share3.00.01.075.0%11.00.01.091.7%18.00.02.090.0%29.00.011.072.5%29.00.031.048.3%
Total Gains per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%38.02.00.095.0%51.07.02.085.0%

Fundamentals of Biogaia

About BioGaia AB (publ)

BioGaia AB (publ), a healthcare company, provides probiotic products worldwide. The company operates through Pediatrics, Adult Health, and Other segments. The Pediatrics segment offers drops, oral rehydration solutions, and gut health tablets, as well as cultures that are used as an ingredient in infant formula. The Adult Health segment provides gut health tablets and oral health lozenges products, as well as cultures, which are used as an ingredient in a licensee's dairy product. The Other segment provides packaging solutions. It sells its products through distribution partners or through its own distribution channels. BioGaia AB (publ) was founded in 1990 and is based in Stockholm, Sweden.

Fundamental data was last updated by Penke on 2024-03-29 02:52:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very efficient.
The company is efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is overpriced.
Based on the earnings, the company is overpriced.
Based on how much money comes from the company's main activities, the company is underpriced.

1.1. Profitability of BioGaia AB (publ).

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Biogaia earns for each kr1 of revenue.

  • Above 10% is considered healthy but always compare Biogaia to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 22.6% means that kr0.23 for each kr1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of BioGaia AB (publ):

  • The MRQ is 22.6%. The company is making a huge profit. +2
  • The TTM is 28.0%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ22.6%TTM28.0%-5.3%
TTM28.0%YOY34.0%-6.0%
TTM28.0%5Y26.8%+1.2%
5Y26.8%10Y27.2%-0.4%
1.1.2. Return on Assets

Shows how efficient Biogaia is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Biogaia to the Drug Manufacturers - Specialty & Generic industry mean.
  • 2.9% Return on Assets means that Biogaia generated kr0.03 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of BioGaia AB (publ):

  • The MRQ is 2.9%. Using its assets, the company is less efficient in making profit.
  • The TTM is 4.0%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ2.9%TTM4.0%-1.1%
TTM4.0%YOY4.3%-0.3%
TTM4.0%5Y4.7%-0.7%
5Y4.7%10Y6.4%-1.7%
1.1.3. Return on Equity

Shows how efficient Biogaia is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Biogaia to the Drug Manufacturers - Specialty & Generic industry mean.
  • 3.3% Return on Equity means Biogaia generated kr0.03 for each kr1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of BioGaia AB (publ):

  • The MRQ is 3.3%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 4.6%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ3.3%TTM4.6%-1.2%
TTM4.6%YOY4.9%-0.4%
TTM4.6%5Y5.8%-1.3%
5Y5.8%10Y7.9%-2.1%

1.2. Operating Efficiency of BioGaia AB (publ).

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Biogaia is operating .

  • Measures how much profit Biogaia makes for each kr1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Biogaia to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 29.9% means the company generated kr0.30  for each kr1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of BioGaia AB (publ):

  • The MRQ is 29.9%. The company is operating very efficient. +2
  • The TTM is 35.4%. The company is operating very efficient. +2
Trends
Current periodCompared to+/- 
MRQ29.9%TTM35.4%-5.4%
TTM35.4%YOY40.2%-4.8%
TTM35.4%5Y33.7%+1.7%
5Y33.7%10Y34.6%-0.9%
1.2.2. Operating Ratio

Measures how efficient Biogaia is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 0.70 means that the operating costs are kr0.70 for each kr1 in net sales.

Let's take a look of the Operating Ratio trends of BioGaia AB (publ):

  • The MRQ is 0.701. The company is efficient in keeping operating costs low. +1
  • The TTM is 0.655. The company is efficient in keeping operating costs low. +1
Trends
Current periodCompared to+/- 
MRQ0.701TTM0.655+0.046
TTM0.655YOY0.697-0.042
TTM0.6555Y0.678-0.024
5Y0.67810Y0.663+0.016

1.3. Liquidity of BioGaia AB (publ).

1.3. Liquidity
1.3.1. Current Ratio

Measures if Biogaia is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 9.58 means the company has kr9.58 in assets for each kr1 in short-term debts.

Let's take a look of the Current Ratio trends of BioGaia AB (publ):

  • The MRQ is 9.576. The company is very able to pay all its short-term debts. +2
  • The TTM is 9.056. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ9.576TTM9.056+0.520
TTM9.056YOY10.281-1.225
TTM9.0565Y8.681+0.375
5Y8.68110Y6.463+2.218
1.3.2. Quick Ratio

Measures if Biogaia is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Biogaia to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 8.43 means the company can pay off kr8.43 for each kr1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of BioGaia AB (publ):

  • The MRQ is 8.430. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 7.471. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ8.430TTM7.471+0.959
TTM7.471YOY8.298-0.826
TTM7.4715Y7.072+0.399
5Y7.07210Y4.971+2.102

1.4. Solvency of BioGaia AB (publ).

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Biogaia assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Biogaia to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.13 means that Biogaia assets are financed with 13.0% credit (debt) and the remaining percentage (100% - 13.0%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of BioGaia AB (publ):

  • The MRQ is 0.130. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.124. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.130TTM0.124+0.006
TTM0.124YOY0.134-0.010
TTM0.1245Y0.158-0.034
5Y0.15810Y0.175-0.017
1.4.2. Debt to Equity Ratio

Measures if Biogaia is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Biogaia to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 14.9% means that company has kr0.15 debt for each kr1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of BioGaia AB (publ):

  • The MRQ is 0.149. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.142. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.149TTM0.142+0.007
TTM0.142YOY0.156-0.014
TTM0.1425Y0.196-0.054
5Y0.19610Y0.219-0.022

2. Market Valuation of BioGaia AB (publ)

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every kr1 in earnings Biogaia generates.

  • Above 15 is considered overpriced but always compare Biogaia to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 37.93 means the investor is paying kr37.93 for every kr1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of BioGaia AB (publ):

  • The EOD is 44.413. Based on the earnings, the company is overpriced. -1
  • The MRQ is 37.929. Based on the earnings, the company is overpriced. -1
  • The TTM is 29.823. Based on the earnings, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD44.413MRQ37.929+6.484
MRQ37.929TTM29.823+8.106
TTM29.823YOY64.515-34.691
TTM29.8235Y185.348-155.524
5Y185.34810Y185.006+0.341
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of BioGaia AB (publ):

  • The EOD is 27.721. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The MRQ is 23.674. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The TTM is 28.086. Based on how much money comes from the company's main activities, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD27.721MRQ23.674+4.047
MRQ23.674TTM28.086-4.412
TTM28.086YOY65.768-37.682
TTM28.0865Y407.572-379.487
5Y407.57210Y302.258+105.314
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Biogaia is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of BioGaia AB (publ):

  • The EOD is 5.894. Based on the equity, the company is overpriced. -1
  • The MRQ is 5.033. Based on the equity, the company is overpriced. -1
  • The TTM is 5.202. Based on the equity, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD5.894MRQ5.033+0.860
MRQ5.033TTM5.202-0.169
TTM5.202YOY10.838-5.635
TTM5.2025Y40.529-35.326
5Y40.52910Y53.235-12.706
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of BioGaia AB (publ) compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.4460.143+211%0.058+664%0.744-40%0.421+6%
Book Value Per Share--20.10619.772+2%18.644+8%14.185+42%9.152+120%
Current Ratio--9.5769.056+6%10.281-7%8.681+10%6.463+48%
Debt To Asset Ratio--0.1300.124+4%0.134-3%0.158-18%0.175-26%
Debt To Equity Ratio--0.1490.142+5%0.156-4%0.196-24%0.219-32%
Dividend Per Share---1.458-100%2.987-100%1.436-100%1.088-100%
Eps--0.6670.904-26%0.926-28%0.656+2%0.538+24%
Free Cash Flow Per Share--1.0690.929+15%0.738+45%0.594+80%0.478+124%
Free Cash Flow To Equity Per Share--0.9930.165+502%-0.038+104%0.691+44%0.261+280%
Gross Profit Margin---0.446-0.047-90%0.098-554%-0.024-95%0.079-665%
Intrinsic Value_10Y_max--54.491--------
Intrinsic Value_10Y_min--31.990--------
Intrinsic Value_1Y_max--3.262--------
Intrinsic Value_1Y_min--2.144--------
Intrinsic Value_3Y_max--11.476--------
Intrinsic Value_3Y_min--7.400--------
Intrinsic Value_5Y_max--21.710--------
Intrinsic Value_5Y_min--13.665--------
Market Cap11527561500.000+11%10219409772.00010339807278.000-1%20795617603.250-51%33664626926.250-70%30220491241.328-66%
Net Profit Margin--0.2260.280-19%0.340-33%0.268-16%0.272-17%
Operating Margin--0.2990.354-15%0.402-25%0.337-11%0.346-13%
Operating Ratio--0.7010.655+7%0.697+1%0.678+3%0.663+6%
Pb Ratio5.894+15%5.0335.202-3%10.838-54%40.529-88%53.235-91%
Pe Ratio44.413+15%37.92929.823+27%64.515-41%185.348-80%185.006-79%
Price Per Share118.500+15%101.200102.393-1%206.003-51%343.729-71%309.491-67%
Price To Free Cash Flow Ratio27.721+15%23.67428.086-16%65.768-64%407.572-94%302.258-92%
Price To Total Gains Ratio265.537+15%226.771115.399+97%84.105+170%344.734-34%362.125-37%
Quick Ratio--8.4307.471+13%8.298+2%7.072+19%4.971+70%
Return On Assets--0.0290.040-28%0.043-33%0.047-39%0.064-55%
Return On Equity--0.0330.046-27%0.049-33%0.058-43%0.079-58%
Total Gains Per Share--0.4461.602-72%3.045-85%2.180-80%1.509-70%
Usd Book Value--185167372.800182087457.600+2%171559466.400+8%128412126.240+44%82477935.240+125%
Usd Book Value Change Per Share--0.0410.013+211%0.005+664%0.068-40%0.038+6%
Usd Book Value Per Share--1.8341.803+2%1.700+8%1.294+42%0.835+120%
Usd Dividend Per Share---0.133-100%0.272-100%0.131-100%0.099-100%
Usd Eps--0.0610.082-26%0.084-28%0.060+2%0.049+24%
Usd Free Cash Flow--9842212.8008551801.200+15%6792393.600+45%5382031.200+83%4293953.640+129%
Usd Free Cash Flow Per Share--0.0970.085+15%0.067+45%0.054+80%0.044+124%
Usd Free Cash Flow To Equity Per Share--0.0910.015+502%-0.004+104%0.063+44%0.024+280%
Usd Market Cap1051313608.800+11%932010171.206942990423.754-1%1896560325.416-51%3070213975.674-70%2756108801.209-66%
Usd Price Per Share10.807+15%9.2299.338-1%18.787-51%31.348-71%28.226-67%
Usd Profit--6143140.8008330025.600-26%8522024.400-28%5939286.000+3%4835271.240+27%
Usd Revenue--27156988.80029560336.800-8%25170242.400+8%21436555.440+27%17231353.080+58%
Usd Total Gains Per Share--0.0410.146-72%0.278-85%0.199-80%0.138-70%
 EOD+4 -4MRQTTM+16 -20YOY+19 -175Y+20 -1610Y+22 -14

3.2. Fundamental Score

Let's check the fundamental score of BioGaia AB (publ) based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1544.413
Price to Book Ratio (EOD)Between0-15.894
Net Profit Margin (MRQ)Greater than00.226
Operating Margin (MRQ)Greater than00.299
Quick Ratio (MRQ)Greater than18.430
Current Ratio (MRQ)Greater than19.576
Debt to Asset Ratio (MRQ)Less than10.130
Debt to Equity Ratio (MRQ)Less than10.149
Return on Equity (MRQ)Greater than0.150.033
Return on Assets (MRQ)Greater than0.050.029
Total6/10 (60.0%)

3.3. Technical Score

Let's check the technical score of BioGaia AB (publ) based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5042.600
Ma 20Greater thanMa 50122.105
Ma 50Greater thanMa 100124.264
Ma 100Greater thanMa 200114.545
OpenGreater thanClose120.400
Total3/5 (60.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-12-312023-03-312023-06-302023-09-302023-12-31
Long-term Assets Other  25,842-25,79349352052-520



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in SEK. All numbers in thousands.

Summary
Total Assets2,333,189
Total Liabilities302,845
Total Stockholder Equity2,030,342
 As reported
Total Liabilities 302,845
Total Stockholder Equity+ 2,030,342
Total Assets = 2,333,189

Assets

Total Assets2,333,189
Total Current Assets1,874,432
Long-term Assets458,757
Total Current Assets
Cash And Cash Equivalents 1,544,192
Net Receivables 105,875
Inventory 181,204
Total Current Assets  (as reported)1,874,432
Total Current Assets  (calculated)1,831,271
+/- 43,161
Long-term Assets
Property Plant Equipment 213,328
Goodwill 165,174
Intangible Assets 46,230
Other Assets 0
Long-term Assets  (as reported)458,757
Long-term Assets  (calculated)424,732
+/- 34,025

Liabilities & Shareholders' Equity

Total Current Liabilities195,734
Long-term Liabilities107,111
Total Stockholder Equity2,030,342
Total Current Liabilities
Accounts payable 49,308
Other Current Liabilities 195,734
Total Current Liabilities  (as reported)195,734
Total Current Liabilities  (calculated)245,042
+/- 49,308
Long-term Liabilities
Long-term Liabilities Other 91,932
Long-term Liabilities  (as reported)107,111
Long-term Liabilities  (calculated)91,932
+/- 15,179
Total Stockholder Equity
Common Stock20,196
Other Stockholders Equity 2,010,146
Total Stockholder Equity (as reported)2,030,342
Total Stockholder Equity (calculated)2,030,342
+/-0
Other
Capital Stock20,196
Cash and Short Term Investments 1,544,192
Common Stock Shares Outstanding 100,982
Liabilities and Stockholders Equity 2,333,189
Net Debt -1,544,192
Net Invested Capital 2,030,342
Net Working Capital 1,678,698
Property Plant and Equipment Gross 379,071



Balance Sheet

Currency in SEK. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-06-30
> Total Assets 
0
0
165,332
0
179,814
196,693
196,385
211,943
227,822
237,799
236,256
252,246
279,832
641,690
542,579
525,994
517,022
537,616
381,722
364,938
383,419
487,588
396,065
388,951
415,608
475,798
442,083
452,355
473,178
451,828
412,219
451,325
488,978
563,755
479,463
522,830
576,112
625,124
591,131
598,098
659,973
705,580
596,571
638,678
665,900
717,404
710,285
711,867
1,913,282
1,946,148
1,935,847
1,967,688
2,128,054
2,230,162
2,082,697
2,161,371
2,213,966
2,324,003
2,157,076
2,304,253
2,333,189
2,333,1892,304,2532,157,0762,324,0032,213,9662,161,3712,082,6972,230,1622,128,0541,967,6881,935,8471,946,1481,913,282711,867710,285717,404665,900638,678596,571705,580659,973598,098591,131625,124576,112522,830479,463563,755488,978451,325412,219451,828473,178452,355442,083475,798415,608388,951396,065487,588383,419364,938381,722537,616517,022525,994542,579641,690279,832252,246236,256237,799227,822211,943196,385196,693179,8140165,33200
   > Total Current Assets 
0
0
131,399
0
154,133
175,331
175,062
191,021
207,374
222,923
219,062
231,834
255,392
609,239
502,965
482,103
467,812
488,280
329,881
310,041
323,116
424,240
327,126
314,730
332,761
388,583
344,855
349,022
365,061
360,363
321,555
361,395
385,340
455,258
360,375
400,168
454,337
503,085
423,102
432,204
494,415
514,288
397,915
436,321
452,438
504,089
496,486
500,921
1,689,577
1,711,474
1,705,688
1,742,808
1,752,077
1,849,215
1,661,605
1,728,299
1,797,481
1,922,486
1,718,725
1,834,530
1,874,432
1,874,4321,834,5301,718,7251,922,4861,797,4811,728,2991,661,6051,849,2151,752,0771,742,8081,705,6881,711,4741,689,577500,921496,486504,089452,438436,321397,915514,288494,415432,204423,102503,085454,337400,168360,375455,258385,340361,395321,555360,363365,061349,022344,855388,583332,761314,730327,126424,240323,116310,041329,881488,280467,812482,103502,965609,239255,392231,834219,062222,923207,374191,021175,062175,331154,1330131,39900
       Cash And Cash Equivalents 
0
0
68,964
0
100,327
112,255
109,422
125,713
146,903
148,514
126,646
161,434
171,534
529,923
414,499
404,065
374,974
397,624
249,560
243,193
234,271
342,693
239,117
224,125
210,666
249,953
202,752
219,803
226,882
221,494
148,205
201,554
243,069
320,617
202,582
240,154
305,856
347,871
215,477
257,491
284,962
315,121
160,059
212,953
213,831
284,135
242,546
292,385
1,467,883
1,486,770
1,468,935
1,529,736
1,484,680
1,571,693
1,356,344
1,402,409
1,488,366
1,580,822
1,369,566
1,452,528
1,544,192
1,544,1921,452,5281,369,5661,580,8221,488,3661,402,4091,356,3441,571,6931,484,6801,529,7361,468,9351,486,7701,467,883292,385242,546284,135213,831212,953160,059315,121284,962257,491215,477347,871305,856240,154202,582320,617243,069201,554148,205221,494226,882219,803202,752249,953210,666224,125239,117342,693234,271243,193249,560397,624374,974404,065414,499529,923171,534161,434126,646148,514146,903125,713109,422112,255100,327068,96400
       Short-term Investments 
0
0
0
0
80
0
0
0
80
0
0
0
80
0
0
0
80
0
0
0
80
0
0
0
13
0
0
0
13
0
0
0
13
0
0
0
5,000
0
0
0
4,832
0
0
0
4,983
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000004,9830004,8320005,00000013000130001300080000800008000080000800000
       Net Receivables 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
98,558
0
0
0
105,251
0
0
0
154,819
0
0
0
156,316
0
0
0
143,196
0
0
0
164,456
0
0
0
-142,838
0
0
0
105,875
105,875000-142,838000164,456000143,196000156,316000154,819000105,25100098,55800000000000000000000000000000000
       Other Current Assets 
0
0
62,435
0
40,549
63,076
65,640
65,308
46,363
74,409
92,416
70,400
62,250
79,316
88,466
78,038
71,913
90,656
80,321
66,848
74,180
81,547
88,009
90,605
100,934
138,630
142,103
129,219
94,620
138,869
173,350
159,841
101,779
134,641
157,793
160,014
110,869
155,214
207,625
174,713
160,408
199,167
237,856
223,368
165,179
219,954
253,940
208,536
149,417
224,704
236,753
213,072
267,397
277,522
305,261
325,890
309,115
341,664
349,159
382,002
330,240
330,240382,002349,159341,664309,115325,890305,261277,522267,397213,072236,753224,704149,417208,536253,940219,954165,179223,368237,856199,167160,408174,713207,625155,214110,869160,014157,793134,641101,779159,841173,350138,86994,620129,219142,103138,630100,93490,60588,00981,54774,18066,84880,32190,65671,91378,03888,46679,31662,25070,40092,41674,40946,36365,30865,64063,07640,549062,43500
   > Long-term Assets 
0
0
33,933
0
25,681
21,362
21,323
20,922
20,448
14,876
17,194
20,412
24,440
32,451
39,614
43,891
49,210
49,336
51,841
54,897
60,303
63,348
68,939
74,221
82,847
87,215
97,228
103,333
108,117
91,465
90,664
89,930
103,638
108,497
119,088
122,662
121,775
122,039
161,174
165,894
165,558
191,292
198,656
202,357
213,462
213,315
213,799
210,946
223,705
234,674
230,159
224,880
375,977
380,947
421,092
433,072
416,485
401,517
438,351
469,723
458,757
458,757469,723438,351401,517416,485433,072421,092380,947375,977224,880230,159234,674223,705210,946213,799213,315213,462202,357198,656191,292165,558165,894161,174122,039121,775122,662119,088108,497103,63889,93090,66491,465108,117103,33397,22887,21582,84774,22168,93963,34860,30354,89751,84149,33649,21043,89139,61432,45124,44020,41217,19414,87620,44820,92221,32321,36225,681033,93300
       Property Plant Equipment 
0
0
5,224
0
5,424
5,141
4,999
4,550
4,216
13,926
16,484
19,941
24,158
32,256
39,506
43,874
49,194
49,319
51,824
0
60,286
63,331
67,121
70,512
72,752
74,787
79,431
84,199
83,934
83,741
83,230
82,395
82,429
87,769
99,075
9,552
102,463
103,388
107,098
104,963
105,933
131,947
136,616
139,172
149,392
149,284
151,332
149,681
162,765
151,581
148,076
143,720
153,635
153,261
164,237
163,321
157,726
152,293
178,091
208,776
213,328
213,328208,776178,091152,293157,726163,321164,237153,261153,635143,720148,076151,581162,765149,681151,332149,284149,392139,172136,616131,947105,933104,963107,098103,388102,4639,55299,07587,76982,42982,39583,23083,74183,93484,19979,43174,78772,75270,51267,12163,33160,286051,82449,31949,19443,87439,50632,25624,15819,94116,48413,9264,2164,5504,9995,1415,42405,22400
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5,300
5,300
5,300
5,300
5,300
5,300
5,300
5,300
5,300
5,300
5,300
5,300
149,227
152,730
168,014
182,343
171,517
170,084
178,059
177,906
165,174
165,174177,906178,059170,084171,517182,343168,014152,730149,2275,3005,3005,3005,3005,3005,3005,3005,3005,3005,3005,3005,3000000000000000000000000000000000000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
10,752
10,252
9,752
9,552
9,932
9,432
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000009,4329,9329,5529,75210,25210,75200000000000000000000000000000000
       Intangible Assets 
0
0
0
0
2,285
1,931
1,577
1,413
1,173
933
693
453
0
177
0
0
0
0
0
0
0
0
0
0
6,075
0
0
0
16,225
0
0
0
0
0
0
0
0
0
52,242
52,242
45,850
45,850
49,080
50,222
52,558
51,999
51,440
50,881
50,322
49,763
49,204
48,645
48,086
47,713
46,968
46,409
46,075
46,128
46,154
46,172
46,230
46,23046,17246,15446,12846,07546,40946,96847,71348,08648,64549,20449,76350,32250,88151,44051,99952,55850,22249,08045,85045,85052,24252,24200000000016,2250006,075000000000017704536939331,1731,4131,5771,9312,2850000
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
10,456
10,476
10,261
10,049
9,378
9,219
329,203
8,689
8,473
8,195
7,660
7,663
6,562
6,732
5,727
5,084
5,318
5,801
5,350
4,986
2,800
5,014
16,080
15,206
15,325
7,170
7,982
8,804
0
08,8047,9827,17015,32515,20616,0805,0142,8004,9865,3505,8015,3185,0845,7276,7326,5627,6637,6608,1958,4738,689329,2039,2199,37810,04910,26110,47610,45600000000000000000000000000000000
> Total Liabilities 
0
0
18,435
0
18,696
23,410
34,154
37,624
40,499
35,133
44,271
43,682
49,477
128,836
114,607
84,299
60,228
63,724
63,662
63,682
66,562
73,594
85,013
63,372
71,017
87,295
88,964
78,129
77,345
71,800
78,637
81,893
73,798
105,774
103,807
104,607
112,224
118,715
163,632
147,015
151,852
162,091
180,001
183,664
158,026
170,640
152,899
134,307
167,037
148,508
150,844
128,876
250,687
273,516
336,066
312,528
241,548
237,135
273,269
318,980
302,845
302,845318,980273,269237,135241,548312,528336,066273,516250,687128,876150,844148,508167,037134,307152,899170,640158,026183,664180,001162,091151,852147,015163,632118,715112,224104,607103,807105,77473,79881,89378,63771,80077,34578,12988,96487,29571,01763,37285,01373,59466,56263,68263,66263,72460,22884,299114,607128,83649,47743,68244,27135,13340,49937,62434,15423,41018,696018,43500
   > Total Current Liabilities 
0
0
18,435
0
18,696
23,410
34,154
37,624
40,499
35,133
44,271
43,682
49,292
128,651
114,422
84,114
35,518
39,075
39,013
39,033
66,477
73,509
84,928
63,287
70,825
87,103
88,772
77,937
76,994
71,449
78,286
81,542
73,466
105,442
103,475
104,275
111,446
117,937
155,999
139,382
145,173
139,156
147,972
153,356
124,800
138,954
123,331
106,129
135,062
120,658
123,594
104,057
126,954
153,018
203,215
173,367
164,991
186,275
217,764
217,488
195,734
195,734217,488217,764186,275164,991173,367203,215153,018126,954104,057123,594120,658135,062106,129123,331138,954124,800153,356147,972139,156145,173139,382155,999117,937111,446104,275103,475105,44273,46681,54278,28671,44976,99477,93788,77287,10370,82563,28784,92873,50966,47739,03339,01339,07535,51884,114114,422128,65149,29243,68244,27135,13340,49937,62434,15423,41018,696018,43500
       Short-term Debt 
0
0
18,435
0
664
23,410
34,154
0
1,029
0
44,271
43,682
0
128,651
114,422
84,114
0
39,075
39,013
39,033
0
73,509
84,928
63,287
0
83,203
84,872
74,037
0
71,449
78,286
81,542
0
105,442
103,475
104,275
0
117,937
0
0
0
6,900
0
0
8,900
0
0
0
8,900
0
0
0
0
0
0
0
0
0
0
0
0
0000000000008,9000008,900006,900000117,9370104,275103,475105,442081,54278,28671,449074,03784,87283,203063,28784,92873,509039,03339,01339,075084,114114,422128,651043,68244,27101,029034,15423,410664018,43500
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
6,900
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000006,90000000000000000000000000000000000000000000
       Accounts payable 
0
0
0
0
8,100
0
0
0
9,373
0
0
0
17,769
0
0
0
14,731
0
0
0
17,808
0
0
0
16,952
0
0
0
23,638
0
0
0
16,951
0
0
0
20,893
0
0
0
34,009
0
0
0
28,491
0
0
0
48,046
0
0
0
42,313
0
0
0
32,050
0
0
0
49,308
49,30800032,05000042,31300048,04600028,49100034,00900020,89300016,95100023,63800016,95200017,80800014,73100017,7690009,3730008,1000000
       Other Current Liabilities 
0
0
0
0
9,932
0
0
37,624
30,097
35,133
0
0
31,523
0
0
0
20,787
0
0
0
48,669
0
0
0
53,873
3,900
3,900
3,900
53,356
0
0
0
56,515
105,442
103,475
104,275
90,553
117,937
155,999
139,382
111,164
139,156
147,972
153,356
87,409
138,954
123,331
106,129
78,116
120,658
123,594
104,057
126,954
153,018
203,215
173,367
132,941
186,275
217,764
217,488
195,734
195,734217,488217,764186,275132,941173,367203,215153,018126,954104,057123,594120,65878,116106,129123,331138,95487,409153,356147,972139,156111,164139,382155,999117,93790,553104,275103,475105,44256,51500053,3563,9003,9003,90053,87300048,66900020,78700031,5230035,13330,09737,624009,9320000
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
185
185
185
185
24,710
24,649
24,649
24,649
85
85
85
85
192
192
192
192
351
351
351
351
332
332
332
332
778
778
7,633
7,633
6,679
22,935
32,029
30,308
33,226
31,686
29,568
28,178
31,975
27,850
27,250
24,819
123,733
120,498
132,851
139,161
76,557
50,860
55,505
101,492
107,111
107,111101,49255,50550,86076,557139,161132,851120,498123,73324,81927,25027,85031,97528,17829,56831,68633,22630,30832,02922,9356,6797,6337,6337787783323323323323513513513511921921921928585858524,64924,64924,64924,710185185185185000000000000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
20,700
0
0
0
10,400
0
0
0
0
0
0
0
0
0000000010,40000020,700000000000000000000000000000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
332
332
332
332
778
778
7,633
7,633
6,679
6,679
18,120
18,120
21,826
31,686
29,568
28,178
11,310
11,218
11,218
11,218
113,920
120,498
132,851
139,161
71,644
0
55,505
101,492
0
0101,49255,505071,644139,161132,851120,498113,92011,21811,21811,21811,31028,17829,56831,68621,82618,12018,1206,6796,6797,6337,63377877833233233233200000000000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
45,850
0
49,080
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000049,080045,8500000000000000000000000000000000000000000
> Total Stockholder Equity
0
0
146,798
0
161,284
173,498
162,499
174,632
187,225
204,662
193,478
209,320
229,764
511,876
425,742
439,156
453,303
469,432
312,027
301,739
317,341
414,719
311,994
326,658
344,492
388,404
353,021
374,129
395,851
380,046
333,600
369,450
415,198
457,999
375,672
418,239
463,904
506,425
410,932
447,849
504,982
540,457
416,568
455,012
507,872
546,762
557,384
577,558
1,746,243
1,797,638
1,785,001
1,838,810
1,877,365
1,956,644
1,746,629
1,848,841
1,972,416
2,086,866
1,883,805
1,985,271
2,030,342
2,030,3421,985,2711,883,8052,086,8661,972,4161,848,8411,746,6291,956,6441,877,3651,838,8101,785,0011,797,6381,746,243577,558557,384546,762507,872455,012416,568540,457504,982447,849410,932506,425463,904418,239375,672457,999415,198369,450333,600380,046395,851374,129353,021388,404344,492326,658311,994414,719317,341301,739312,027469,432453,303439,156425,742511,876229,764209,320193,478204,662187,225174,632162,499173,498161,2840146,79800
   Common Stock
0
0
0
0
17,208
0
0
0
17,271
0
0
0
17,271
511,876
0
0
17,271
0
0
0
17,271
0
0
0
17,271
0
0
0
17,336
0
0
0
17,336
457,999
375,672
418,239
17,336
506,425
410,932
447,849
17,336
540,457
416,568
17,336
17,336
546,762
557,384
577,558
20,196
1,797,638
1,785,001
1,838,810
20,196
1,956,644
1,746,629
1,848,841
20,196
20,196
20,196
20,196
20,196
20,19620,19620,19620,19620,1961,848,8411,746,6291,956,64420,1961,838,8101,785,0011,797,63820,196577,558557,384546,76217,33617,336416,568540,45717,336447,849410,932506,42517,336418,239375,672457,99917,33600017,33600017,27100017,27100017,27100511,87617,27100017,27100017,2080000
   Retained Earnings Total Equity0000000000000000000000000000000000000000000000000000000000000
   Accumulated Other Comprehensive Income 0000000000000000000000000000000000000000000000000000000000000
   Capital Surplus 0000000000000000000000000000000000000000000000000000000000000
   Treasury Stock0000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
78,648
0
0
0
125,883
0
0
0
84,145
0
0
0
6,639
0
0
0
5,218
0
0
0
5,860
0
0
0
22,101
0
0
0
22,990
0
0
0
23,555
0
0
0
23,368
0
0
437,676
23,870
546,762
557,384
577,558
1,147,463
1,797,638
1,785,001
1,838,810
1,877,365
1,956,644
1,746,629
1,848,841
1,179,490
2,066,670
1,863,609
1,965,075
2,010,146
2,010,1461,965,0751,863,6092,066,6701,179,4901,848,8411,746,6291,956,6441,877,3651,838,8101,785,0011,797,6381,147,463577,558557,384546,76223,870437,6760023,36800023,55500022,99000022,1010005,8600005,2180006,63900084,145000125,88300078,6480000



Balance Sheet

Currency in SEK. All numbers in thousands.




Cash Flow

Currency in SEK. All numbers in thousands.




Income Statement

Currency in SEK. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue1,296,506
Cost of Revenue-346,316
Gross Profit950,190950,190
 
Operating Income (+$)
Gross Profit950,190
Operating Expense-509,281
Operating Income440,909440,909
 
Operating Expense (+$)
Research Development106,776
Selling General Administrative42,498
Selling And Marketing Expenses354,397
Operating Expense509,281503,671
 
Net Interest Income (+$)
Interest Income18,515
Interest Expense-15,801
Other Finance Cost-13,102
Net Interest Income15,816
 
Pretax Income (+$)
Operating Income440,909
Net Interest Income15,816
Other Non-Operating Income Expenses0
Income Before Tax (EBT)468,834412,984
EBIT - interestExpense = 425,108
468,834
381,153
Interest Expense15,801
Earnings Before Interest and Taxes (EBIT)440,909484,635
Earnings Before Interest and Taxes (EBITDA)466,190
 
After tax Income (+$)
Income Before Tax468,834
Tax Provision-95,671
Net Income From Continuing Ops437,421373,163
Net Income365,352
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses855,597
Total Other Income/Expenses Net27,925-15,816
 

Technical Analysis of Biogaia
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Biogaia. The general trend of Biogaia is BULLISH with 42.9% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Biogaia's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (42.9%) Bearish trend (-42.9%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of BioGaia AB (publ).

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 123.80 < 135.60.

The bearish price targets are: 109.90 > 109.40 > 109.40.

Tweet this
BioGaia AB (publ) Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of BioGaia AB (publ). The current mas is .

The long score for the Moving Averages is 10/14.
The longshort score for the Moving Averages is 6/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

BioGaia AB (publ) Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of BioGaia AB (publ). The current macd is -1.99776767.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Biogaia price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Biogaia. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Biogaia price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
BioGaia AB (publ) Daily Moving Average Convergence/Divergence (MACD) ChartBioGaia AB (publ) Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of BioGaia AB (publ). The current adx is 23.82.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -1/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Biogaia shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
BioGaia AB (publ) Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of BioGaia AB (publ). The current sar is 120.60.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
BioGaia AB (publ) Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of BioGaia AB (publ). The current rsi is 42.60. The current phase is Correction in bull market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Correction in bull market: Moderate price decline, potential pause in the uptrend. Reassess the market, wait for signs of stabilization.
  • Trending down: The RSI is trending down. -1
BioGaia AB (publ) Daily Relative Strength Index (RSI) ChartBioGaia AB (publ) Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of BioGaia AB (publ). The current phase is Correction in bull market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -4/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Biogaia price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
BioGaia AB (publ) Daily Stochastic Oscillator ChartBioGaia AB (publ) Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of BioGaia AB (publ). The current cci is -33.92595927.

BioGaia AB (publ) Daily Commodity Channel Index (CCI) ChartBioGaia AB (publ) Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of BioGaia AB (publ). The current cmo is -15.61010533.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
BioGaia AB (publ) Daily Chande Momentum Oscillator (CMO) ChartBioGaia AB (publ) Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of BioGaia AB (publ). The current willr is -75.13812155.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Biogaia is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
BioGaia AB (publ) Daily Williams %R ChartBioGaia AB (publ) Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of BioGaia AB (publ).

BioGaia AB (publ) Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of BioGaia AB (publ). The current atr is 3.06161366.

BioGaia AB (publ) Daily Average True Range (ATR) ChartBioGaia AB (publ) Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of BioGaia AB (publ). The current obv is 503,537.

BioGaia AB (publ) Daily On-Balance Volume (OBV) ChartBioGaia AB (publ) Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of BioGaia AB (publ). The current mfi is 27.51.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
BioGaia AB (publ) Daily Money Flow Index (MFI) ChartBioGaia AB (publ) Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for BioGaia AB (publ).

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-30MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-01STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-04CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-05SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-06WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-08STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-12MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-13STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-15STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-19STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-12-20CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-27CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-28MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-12-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-02DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-03CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-01-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-08STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-09BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-11ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-12ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-15MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-16STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-17STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-18SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-24SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-26STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-30WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-31STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-05RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-07STOCH LONG EXITThe %K line crosses below the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-09RSI SHORT ENTRY LONG CLOSE70 crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-14STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-15WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-16BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-19RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-21SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-22WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-27MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-29SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-01CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-04MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-06RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-03-07MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-03-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-11SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-12CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-13STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-18STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-20STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-25SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-26MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-03-27STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-28MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-02CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-03WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-18STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

BioGaia AB (publ) Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of BioGaia AB (publ) based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5042.600
Ma 20Greater thanMa 50122.105
Ma 50Greater thanMa 100124.264
Ma 100Greater thanMa 200114.545
OpenGreater thanClose120.400
Total3/5 (60.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Biogaia with someone you think should read this too:
  • Are you bullish or bearish on Biogaia? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Biogaia? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about BioGaia AB (publ)

I send you an email if I find something interesting about BioGaia AB (publ).


Comments

How you think about this?

Leave a comment

Stay informed about BioGaia AB (publ).

Receive notifications about BioGaia AB (publ) in your mailbox!